Active Pharmaceutical Ingredients (API)
The global Active Pharmaceutical Ingredients (API) market was valued at 6175.12 Million USD in 2021 and will grow with a CAGR of 6.28% from 2021 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.The EMEA average price of Active Pharmaceutical Ingredients is in the decreasing trend, from 6695 USD/MT in 2012 to 5483 USD/MT in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
By Market Verdors
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy`s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
By Types
Synthetic APIs
Biotech APIs
By Applications
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Key Indicators Analysed
Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.
Opportunities and DriversIdentifying the Growing Demands and New Technology
Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Active Pharmaceutical Ingredients (API) Revenue
1.4 Market Analysis by Type
1.4.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Synthetic APIs
1.4.3 Biotech APIs
1.5 Market by Application
1.5.1 Global Active Pharmaceutical Ingredients (API) Market Share by Application: 2022-2027
1.5.2 CNS
1.5.3 Cardiovascular
1.5.4 Genitourinary/Hormonal Drugs
1.5.5 Respiratory
1.5.6 Rheumatology
1.5.7 Diabetes
1.5.8 Oncology
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Active Pharmaceutical Ingredients (API) Market
1.8.1 Global Active Pharmaceutical Ingredients (API) Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Active Pharmaceutical Ingredients (API) Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Active Pharmaceutical Ingredients (API) Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share by Region (2016-2021)
3.2 Global Active Pharmaceutical Ingredients (API) Sales Revenue Market Share by Region (2016-2021)
3.3 North America Active Pharmaceutical Ingredients (API) Sales Volume
3.3.1 North America Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
3.3.2 North America Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Active Pharmaceutical Ingredients (API) Sales Volume
3.4.1 East Asia Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Active Pharmaceutical Ingredients (API) Sales Volume (2016-2021)
3.5.1 Europe Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Active Pharmaceutical Ingredients (API) Sales Volume (2016-2021)
3.6.1 South Asia Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Volume (2016-2021)
3.7.1 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Active Pharmaceutical Ingredients (API) Sales Volume (2016-2021)
3.8.1 Middle East Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Active Pharmaceutical Ingredients (API) Sales Volume (2016-2021)
3.9.1 Africa Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Active Pharmaceutical Ingredients (API) Sales Volume (2016-2021)
3.10.1 Oceania Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Active Pharmaceutical Ingredients (API) Sales Volume (2016-2021)
3.11.1 South America Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
3.11.2 South America Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Active Pharmaceutical Ingredients (API) Sales Volume (2016-2021)
3.12.1 Rest of the World Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Active Pharmaceutical Ingredients (API) Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Active Pharmaceutical Ingredients (API) Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Active Pharmaceutical Ingredients (API) Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Active Pharmaceutical Ingredients (API) Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Active Pharmaceutical Ingredients (API) Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Active Pharmaceutical Ingredients (API) Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Active Pharmaceutical Ingredients (API) Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Active Pharmaceutical Ingredients (API) Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Active Pharmaceutical Ingredients (API) Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Active Pharmaceutical Ingredients (API) Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share by Type (2016-2021)
14.2 Global Active Pharmaceutical Ingredients (API) Sales Revenue Market Share by Type (2016-2021)
14.3 Global Active Pharmaceutical Ingredients (API) Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Active Pharmaceutical Ingredients (API) Consumption Volume by Application (2016-2021)
15.2 Global Active Pharmaceutical Ingredients (API) Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Active Pharmaceutical Ingredients (API) Business
16.1 Teva
16.1.1 Teva Company Profile
16.1.2 Teva Active Pharmaceutical Ingredients (API) Product Specification
16.1.3 Teva Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Mylan
16.2.1 Mylan Company Profile
16.2.2 Mylan Active Pharmaceutical Ingredients (API) Product Specification
16.2.3 Mylan Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 DSM
16.3.1 DSM Company Profile
16.3.2 DSM Active Pharmaceutical Ingredients (API) Product Specification
16.3.3 DSM Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Aurobindo Pharma
16.4.1 Aurobindo Pharma Company Profile
16.4.2 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Specification
16.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Aspen
16.5.1 Aspen Company Profile
16.5.2 Aspen Active Pharmaceutical Ingredients (API) Product Specification
16.5.3 Aspen Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Novartis
16.6.1 Novartis Company Profile
16.6.2 Novartis Active Pharmaceutical Ingredients (API) Product Specification
16.6.3 Novartis Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 BASF
16.7.1 BASF Company Profile
16.7.2 BASF Active Pharmaceutical Ingredients (API) Product Specification
16.7.3 BASF Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Pfizer
16.8.1 Pfizer Company Profile
16.8.2 Pfizer Active Pharmaceutical Ingredients (API) Product Specification
16.8.3 Pfizer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Huahai Pharmaceutical
16.9.1 Huahai Pharmaceutical Company Profile
16.9.2 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification
16.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Hisun Pharmaceutical
16.10.1 Hisun Pharmaceutical Company Profile
16.10.2 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification
16.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Sun Pharmaceutical Industries
16.11.1 Sun Pharmaceutical Industries Company Profile
16.11.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Specification
16.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Zhejiang Medicine
16.12.1 Zhejiang Medicine Company Profile
16.12.2 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Specification
16.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Dr. Reddy`s Laboratories
16.13.1 Dr. Reddy`s Laboratories Company Profile
16.13.2 Dr. Reddy`s Laboratories Active Pharmaceutical Ingredients (API) Product Specification
16.13.3 Dr. Reddy`s Laboratories Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 Zhejiang NHU
16.14.1 Zhejiang NHU Company Profile
16.14.2 Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Specification
16.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Bayer
16.15.1 Bayer Company Profile
16.15.2 Bayer Active Pharmaceutical Ingredients (API) Product Specification
16.15.3 Bayer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 NCPC
16.16.1 NCPC Company Profile
16.16.2 NCPC Active Pharmaceutical Ingredients (API) Product Specification
16.16.3 NCPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.17 AbbVie
16.17.1 AbbVie Company Profile
16.17.2 AbbVie Active Pharmaceutical Ingredients (API) Product Specification
16.17.3 AbbVie Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.18 Shandong Xinhua Pharmaceutical
16.18.1 Shandong Xinhua Pharmaceutical Company Profile
16.18.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification
16.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.19 Northeast Pharm
16.19.1 Northeast Pharm Company Profile
16.19.2 Northeast Pharm Active Pharmaceutical Ingredients (API) Product Specification
16.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.20 Harbin Pharmaceutical
16.20.1 Harbin Pharmaceutical Company Profile
16.20.2 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification
16.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.21 LKPC
16.21.1 LKPC Company Profile
16.21.2 LKPC Active Pharmaceutical Ingredients (API) Product Specification
16.21.3 LKPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Active Pharmaceutical Ingredients (API) Manufacturing Cost Analysis
17.1 Active Pharmaceutical Ingredients (API) Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)
17.4 Active Pharmaceutical Ingredients (API) Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Active Pharmaceutical Ingredients (API) Distributors List
18.3 Active Pharmaceutical Ingredients (API) Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Active Pharmaceutical Ingredients (API) (2022-2027)
20.2 Global Forecasted Revenue of Active Pharmaceutical Ingredients (API) (2022-2027)
20.3 Global Forecasted Price of Active Pharmaceutical Ingredients (API) (2016-2027)
20.4 Global Forecasted Production of Active Pharmaceutical Ingredients (API) by Region (2022-2027)
20.4.1 North America Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
20.4.3 Europe Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
20.4.7 Africa Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
20.4.9 South America Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
21.2 East Asia Market Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
21.3 Europe Market Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Countriy
21.4 South Asia Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
21.5 Southeast Asia Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
21.6 Middle East Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
21.7 Africa Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
21.8 Oceania Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
21.9 South America Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
21.10 Rest of the world Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
List of Figure
Key Players Covered: Ranking by Active Pharmaceutical Ingredients (API) Revenue (US$ Million) 2016-2021
Global Active Pharmaceutical Ingredients (API) Market Size by Type (US$ Million): 2022-2027
Global Active Pharmaceutical Ingredients (API) Market Size by Application (US$ Million): 2022-2027
Global Active Pharmaceutical Ingredients (API) Production Capacity by Manufacturers
Global Active Pharmaceutical Ingredients (API) Production by Manufacturers (2016-2021)
Global Active Pharmaceutical Ingredients (API) Production Market Share by Manufacturers (2016-2021)
Global Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2016-2021)
Global Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2016-2021)
Global Market Active Pharmaceutical Ingredients (API) Average Price of Key Manufacturers (2016-2021)
Manufacturers Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Manufacturers Active Pharmaceutical Ingredients (API) Product Type
Global Active Pharmaceutical Ingredients (API) Sales Volume by Region (2016-2021)
Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share by Region (2016-2021)
Global Active Pharmaceutical Ingredients (API) Sales Revenue by Region (2016-2021)
Global Active Pharmaceutical Ingredients (API) Sales Revenue Market Share by Region (2016-2021)
North America Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
East Asia Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Europe Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South Asia Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Southeast Asia Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Middle East Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Africa Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Oceania Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South America Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Rest of the World Active Pharmaceutical Ingredients (API) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
North America Active Pharmaceutical Ingredients (API) Consumption by Countries (2016-2021)
East Asia Active Pharmaceutical Ingredients (API) Consumption by Countries (2016-2021)
Europe Active Pharmaceutical Ingredients (API) Consumption by Region (2016-2021)
South Asia Active Pharmaceutical Ingredients (API) Consumption by Countries (2016-2021)
Southeast Asia Active Pharmaceutical Ingredients (API) Consumption by Countries (2016-2021)
Middle East Active Pharmaceutical Ingredients (API) Consumption by Countries (2016-2021)
Africa Active Pharmaceutical Ingredients (API) Consumption by Countries (2016-2021)
Oceania Active Pharmaceutical Ingredients (API) Consumption by Countries (2016-2021)
South America Active Pharmaceutical Ingredients (API) Consumption by Countries (2016-2021)
Rest of the World Active Pharmaceutical Ingredients (API) Consumption by Countries (2016-2021)
Global Active Pharmaceutical Ingredients (API) Sales Volume by Type (2016-2021)
Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share by Type (2016-2021)
Global Active Pharmaceutical Ingredients (API) Sales Revenue by Type (2016-2021)
Global Active Pharmaceutical Ingredients (API) Sales Revenue Share by Type (2016-2021)
Global Active Pharmaceutical Ingredients (API) Sales Price by Type (2016-2021)
Global Active Pharmaceutical Ingredients (API) Consumption Volume by Application (2016-2021)
Global Active Pharmaceutical Ingredients (API) Consumption Volume Market Share by Application (2016-2021)
Global Active Pharmaceutical Ingredients (API) Consumption Value by Application (2016-2021)
Global Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Application (2016-2021)
Teva Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Mylan Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
DSM Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Aspen Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Novartis Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
BASF Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Pfizer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Dr. Reddy`s Laboratories Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bayer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
NCPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
AbbVie Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Northeast Pharm Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
LKPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Active Pharmaceutical Ingredients (API) Distributors List
Active Pharmaceutical Ingredients (API) Customers List
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2022-2027)
Key Challenges
Global Active Pharmaceutical Ingredients (API) Production Forecast by Region (2022-2027)
Global Active Pharmaceutical Ingredients (API) Sales Volume Forecast by Type (2022-2027)
Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share Forecast by Type (2022-2027)
Global Active Pharmaceutical Ingredients (API) Sales Revenue Forecast by Type (2022-2027)
Global Active Pharmaceutical Ingredients (API) Sales Revenue Market Share Forecast by Type (2022-2027)
Global Active Pharmaceutical Ingredients (API) Sales Price Forecast by Type (2022-2027)
Global Active Pharmaceutical Ingredients (API) Consumption Volume Forecast by Application (2022-2027)
Global Active Pharmaceutical Ingredients (API) Consumption Value Forecast by Application (2022-2027)
North America Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027 by Country
East Asia Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027 by Country
Europe Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027 by Country
South Asia Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027 by Country
Southeast Asia Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027 by Country
Middle East Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027 by Country
Africa Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027 by Country
Oceania Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027 by Country
South America Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027 by Country
Rest of the world Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027 by Country
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Active Pharmaceutical Ingredients (API) Market Share by Type: 2021 VS 2027
Synthetic APIs Features
Biotech APIs Features
Global Active Pharmaceutical Ingredients (API) Market Share by Application: 2021 VS 2027
CNS Case Studies
Cardiovascular Case Studies
Genitourinary/Hormonal Drugs Case Studies
Respiratory Case Studies
Rheumatology Case Studies
Diabetes Case Studies
Oncology Case Studies
Active Pharmaceutical Ingredients (API) Report Years Considered
Global Active Pharmaceutical Ingredients (API) Market Status and Outlook (2016-2027)
North America Active Pharmaceutical Ingredients (API) Revenue (Value) and Growth Rate (2016-2027)
East Asia Active Pharmaceutical Ingredients (API) Revenue (Value) and Growth Rate (2016-2027)
Europe Active Pharmaceutical Ingredients (API) Revenue (Value) and Growth Rate (2016-2027)
South Asia Active Pharmaceutical Ingredients (API) Revenue (Value) and Growth Rate (2016-2027)
South America Active Pharmaceutical Ingredients (API) Revenue (Value) and Growth Rate (2016-2027)
Middle East Active Pharmaceutical Ingredients (API) Revenue (Value) and Growth Rate (2016-2027)
Africa Active Pharmaceutical Ingredients (API) Revenue (Value) and Growth Rate (2016-2027)
Oceania Active Pharmaceutical Ingredients (API) Revenue (Value) and Growth Rate (2016-2027)
South America Active Pharmaceutical Ingredients (API) Revenue (Value) and Growth Rate (2016-2027)
Rest of the World Active Pharmaceutical Ingredients (API) Revenue (Value) and Growth Rate (2016-2027)
North America Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
East Asia Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
Europe Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
South Asia Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
Southeast Asia Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
Middle East Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
Africa Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
Oceania Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
South America Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
Rest of the World Active Pharmaceutical Ingredients (API) Sales Volume Growth Rate (2016-2021)
North America Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
North America Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2021
United States Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Canada Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Mexico Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
East Asia Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
East Asia Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2021
China Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Japan Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
South Korea Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Europe Active Pharmaceutical Ingredients (API) Consumption and Growth Rate
Europe Active Pharmaceutical Ingredients (API) Consumption Market Share by Region in 2021
Germany Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
United Kingdom Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
France Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Italy Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Russia Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Spain Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Netherlands Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Switzerland Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Poland Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
South Asia Active Pharmaceutical Ingredients (API) Consumption and Growth Rate
South Asia Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2021
India Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Pakistan Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Bangladesh Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Southeast Asia Active Pharmaceutical Ingredients (API) Consumption and Growth Rate
Southeast Asia Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2021
Indonesia Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Thailand Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Singapore Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Malaysia Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Philippines Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Vietnam Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Myanmar Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Middle East Active Pharmaceutical Ingredients (API) Consumption and Growth Rate
Middle East Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2021
Turkey Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Saudi Arabia Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Iran Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
United Arab Emirates Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Israel Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Iraq Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Qatar Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Kuwait Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Oman Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Africa Active Pharmaceutical Ingredients (API) Consumption and Growth Rate
Africa Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2021
Nigeria Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
South Africa Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Egypt Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Algeria Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Morocco Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Oceania Active Pharmaceutical Ingredients (API) Consumption and Growth Rate
Oceania Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2021
Australia Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
New Zealand Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
South America Active Pharmaceutical Ingredients (API) Consumption and Growth Rate
South America Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2021
Brazil Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Argentina Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Columbia Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Chile Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Venezuelal Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Peru Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Puerto Rico Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Ecuador Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Rest of the World Active Pharmaceutical Ingredients (API) Consumption and Growth Rate
Rest of the World Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2021
Kazakhstan Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021)
Sales Market Share of Active Pharmaceutical Ingredients (API) by Type in 2021
Sales Revenue Market Share of Active Pharmaceutical Ingredients (API) by Type in 2021
Global Active Pharmaceutical Ingredients (API) Consumption Volume Market Share by Application in 2021
Teva Active Pharmaceutical Ingredients (API) Product Specification
Mylan Active Pharmaceutical Ingredients (API) Product Specification
DSM Active Pharmaceutical Ingredients (API) Product Specification
Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Specification
Aspen Active Pharmaceutical Ingredients (API) Product Specification
Novartis Active Pharmaceutical Ingredients (API) Product Specification
BASF Active Pharmaceutical Ingredients (API) Product Specification
Pfizer Active Pharmaceutical Ingredients (API) Product Specification
Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification
Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification
Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Specification
Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Specification
Dr. Reddy`s Laboratories Active Pharmaceutical Ingredients (API) Product Specification
Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Specification
Bayer Active Pharmaceutical Ingredients (API) Product Specification
NCPC Active Pharmaceutical Ingredients (API) Product Specification
AbbVie Active Pharmaceutical Ingredients (API) Product Specification
Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification
Northeast Pharm Active Pharmaceutical Ingredients (API) Product Specification
Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification
LKPC Active Pharmaceutical Ingredients (API) Product Specification
Manufacturing Cost Structure of Active Pharmaceutical Ingredients (API)
Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)
Active Pharmaceutical Ingredients (API) Industrial Chain Analysis
Channels of Distribution
Distributors Profiles
Porter's Five Forces Analysis
Global Active Pharmaceutical Ingredients (API) Production Capacity Growth Rate Forecast (2022-2027)
Global Active Pharmaceutical Ingredients (API) Revenue Growth Rate Forecast (2022-2027)
Global Active Pharmaceutical Ingredients (API) Price and Trend Forecast (2016-2027)
North America Active Pharmaceutical Ingredients (API) Production Growth Rate Forecast (2022-2027)
North America Active Pharmaceutical Ingredients (API) Revenue Growth Rate Forecast (2022-2027)
East Asia Active Pharmaceutical Ingredients (API) Production Growth Rate Forecast (2022-2027)
East Asia Active Pharmaceutical Ingredients (API) Revenue Growth Rate Forecast (2022-2027)
Europe Active Pharmaceutical Ingredients (API) Production Growth Rate Forecast (2022-2027)
Europe Active Pharmaceutical Ingredients (API) Revenue Growth Rate Forecast (2022-2027)
South Asia Active Pharmaceutical Ingredients (API) Production Growth Rate Forecast (2022-2027)
South Asia Active Pharmaceutical Ingredients (API) Revenue Growth Rate Forecast (2022-2027)
Southeast Asia Active Pharmaceutical Ingredients (API) Production Growth Rate Forecast (2022-2027)
Southeast Asia Active Pharmaceutical Ingredients (API) Revenue Growth Rate Forecast (2022-2027)
Middle East Active Pharmaceutical Ingredients (API) Production Growth Rate Forecast (2022-2027)
Middle East Active Pharmaceutical Ingredients (API) Revenue Growth Rate Forecast (2022-2027)
Africa Active Pharmaceutical Ingredients (API) Production Growth Rate Forecast (2022-2027)
Africa Active Pharmaceutical Ingredients (API) Revenue Growth Rate Forecast (2022-2027)
Oceania Active Pharmaceutical Ingredients (API) Production Growth Rate Forecast (2022-2027)
Oceania Active Pharmaceutical Ingredients (API) Revenue Growth Rate Forecast (2022-2027)
South America Active Pharmaceutical Ingredients (API) Production Growth Rate Forecast (2022-2027)
South America Active Pharmaceutical Ingredients (API) Revenue Growth Rate Forecast (2022-2027)
Rest of the World Active Pharmaceutical Ingredients (API) Production Growth Rate Forecast (2022-2027)
Rest of the World Active Pharmaceutical Ingredients (API) Revenue Growth Rate Forecast (2022-2027)
North America Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027
East Asia Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027
Europe Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027
South Asia Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027
Southeast Asia Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027
Middle East Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027
Africa Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027
Oceania Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027
South America Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027
Rest of the world Active Pharmaceutical Ingredients (API) Consumption Forecast 2022-2027
Bottom-up and Top-down Approaches for This Report
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices